Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Kanabo Group ( (GB:KNB) ).
Kanabo Group plc has announced a business update highlighting financial uncertainties and strategic reassessment. The company is considering restructuring options, including asset disposals and mergers, while evaluating its capital needs and potential fundraising alternatives. Due to these uncertainties, the publication of its audited accounts for the year ending December 2024 will be delayed.
More about Kanabo Group
Kanabo Group plc is a digital health company focused on enhancing patient care through its specialized technology platform and treatments, including medicinal cannabis. The company operates two main divisions: The GP Service, an NHS-approved telehealth platform offering video consultations and online prescriptions, and Treat It, a specialized clinic for chronic pain and mental health care. Kanabo also has a partially owned subsidiary, Kanabo Agritec Ltd, which provides cultivation consultancy to ensure access to high-quality raw materials.
YTD Price Performance: -55.29%
Average Trading Volume: 455,354
Technical Sentiment Signal: Strong Buy
Current Market Cap: £2.4M
For a thorough assessment of KNB stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue